Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
2021 2
2022 5
2023 2

Text availability

Article attribute

Article type

Publication date

Search Results

9 results

Results by year

Filters applied: . Clear all
Page 1
Did you mean sutandi, s[au] (2 results)?
Cross-Neutralizing Breadth and Longevity Against SARS-CoV-2 Variants After Infections.
Kurahashi Y, Sutandhio S, Furukawa K, Tjan LH, Iwata S, Sano S, Tohma Y, Ohkita H, Nakamura S, Nishimura M, Arii J, Kiriu T, Yamamoto M, Nagano T, Nishimura Y, Mori Y. Kurahashi Y, et al. Among authors: sutandhio s. Front Immunol. 2022 Feb 24;13:773652. doi: 10.3389/fimmu.2022.773652. eCollection 2022. Front Immunol. 2022. PMID: 35281007 Free PMC article.
Cross-Neutralizing Activity Against Omicron Could Be Obtained in SARS-CoV-2 Convalescent Patients Who Received Two Doses of mRNA Vaccination.
Kurahashi Y, Furukawa K, Sutandhio S, Tjan LH, Iwata S, Sano S, Tohma Y, Ohkita H, Nakamura S, Nishimura M, Arii J, Kiriu T, Yamamoto M, Nagano T, Nishimura Y, Mori Y. Kurahashi Y, et al. Among authors: sutandhio s. J Infect Dis. 2022 Oct 17;226(8):1391-1395. doi: 10.1093/infdis/jiac178. J Infect Dis. 2022. PMID: 35512332 Free PMC article.
Identification and Analysis of Monoclonal Antibodies with Neutralizing Activity against Diverse SARS-CoV-2 Variants.
Ishimaru H, Nishimura M, Tjan LH, Sutandhio S, Marini MI, Effendi GB, Shigematsu H, Kato K, Hasegawa N, Aoki K, Kurahashi Y, Furukawa K, Shinohara M, Nakamura T, Arii J, Nagano T, Nakamura S, Sano S, Iwata S, Okamura S, Mori Y. Ishimaru H, et al. Among authors: sutandhio s. J Virol. 2023 Jun 29;97(6):e0028623. doi: 10.1128/jvi.00286-23. Epub 2023 May 16. J Virol. 2023. PMID: 37191569 Free PMC article.
Large-scale serosurveillance of COVID-19 in Japan: Acquisition of neutralizing antibodies for Delta but not for Omicron and requirement of booster vaccination to overcome the Omicron's outbreak.
Ren Z, Nishimura M, Tjan LH, Furukawa K, Kurahashi Y, Sutandhio S, Aoki K, Hasegawa N, Arii J, Uto K, Matsui K, Sato I, Saegusa J, Godai N, Takeshita K, Yamamoto M, Nagashima T, Mori Y. Ren Z, et al. Among authors: sutandhio s. PLoS One. 2022 Apr 5;17(4):e0266270. doi: 10.1371/journal.pone.0266270. eCollection 2022. PLoS One. 2022. PMID: 35381036 Free PMC article.
Cross-Neutralizing Activity Against SARS-CoV-2 Variants in COVID-19 Patients: Comparison of 4 Waves of the Pandemic in Japan.
Furukawa K, Tjan LH, Sutandhio S, Kurahashi Y, Iwata S, Tohma Y, Sano S, Nakamura S, Nishimura M, Arii J, Kiriu T, Yamamoto M, Nagano T, Nishimura Y, Mori Y. Furukawa K, et al. Among authors: sutandhio s. Open Forum Infect Dis. 2021 Aug 18;8(10):ofab430. doi: 10.1093/ofid/ofab430. eCollection 2021 Oct. Open Forum Infect Dis. 2021. PMID: 34631915 Free PMC article.
Seroepidemiological Survey of the Antibody for Severe Acute Respiratory Syndrome Coronavirus 2 with Neutralizing Activity at Hospitals: A Cross-sectional Study in Hyogo Prefecture, Japan.
Furukawa K, Arii J, Nishimura M, Tjan LH, Lystia Poetranto A, Ren Z, Aktar S, Huang JR, Sutandhio S, Kurahashi Y, Nishino A, Shigekuni S, Takeda Y, Uto K, Matsui K, Sato I, Inui Y, Endo K, Kosaka Y, Oota T, Saegusa J, Mori Y. Furukawa K, et al. Among authors: sutandhio s. JMA J. 2021 Jan 29;4(1):41-49. doi: 10.31662/jmaj.2020-0094. Epub 2021 Jan 14. JMA J. 2021. PMID: 33575502 Free PMC article.